Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer

K Gao, X Li, J Ni, B Wu, J Guo, R Zhang, G Wu - Cancer Letters, 2023 - Elsevier
Enzalutamide (Enz) is a next-generation androgen receptor (AR) antagonist used to treat
castration-resistant prostate cancer (CRPC). Unfortunately, the relapsing nature of CRPC …
被引用次数：11 相关文章

Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer

K Gao, X Li, J Ni, B Wu, J Guo, R Zhang… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Enzalutamide (Enz) is a next-generation androgen receptor (AR) antagonist used to treat
castration-resistant prostate cancer (CRPC). Unfortunately, the relapsing nature of CRPC …